Search for publications

Search results

4750 items matching your search terms.

Added diagnostic value of peanut component testing: a cross sectional study in Australian children

Kaur, N. Mehr, S. Katelaris, C. Wainstein, B. Altavilla, B. Saad, R. Valerio, C. Codarini, M. Burton, P. Perram, F. Baumgart, K. Barnes, E. H. Campbell, D. E.
J ALLERGY CLIN IMMUNOL PRACT, 2021     DOI:10.1016/j.jaip.2020.08.060

Functional outcome of laparoscopic assisted resection vs open resection of rectal cancer: A secondary analysis of the Australasian Laparoscopic Cancer of the Rectum Trial

Keane, C. R. O'Grady, G. Bissett, I. P. Hayes, J. Hulme-Moir, M. Eglinton, T. W. Solomon, M. J. Lumley, J. W. Simes, J. Stevenson, A. R. L.
DISEASES OF THE COLON AND RECTUM, 2021     DOI:10.1097/DCR.0000000000002166

Efficacy and safety of long-term evolocumab use among Asian subjects- a subgroup analysis of the further cardiovascular outcomes research with PCSK9 inhibition in subjects with elevated risk (FOURIER) trial

Keech, A. C. Oyama, K. Sever, P. S. Tang, M. Murphy, S. A. Hirayama, A. Lu, C. Tay, L. Deedwania, P. C. Siu, C. W. Lira Pineda, A. Choi, D. Charng, M. J. Amerena, J. Wan Ahmad, W. A. Chopra, V. K. Pedersen, T. R. Giugliano, R. P. Sabatine, M. S. Fourier Study Group
CIRCULATION JOURNAL, 2021     DOI:10.1253/circj.CJ-20-1051

Skin care interventions in infants for preventing eczema and food allergy: a Cochrane systematic review and individual participant data meta-analysis

Kelleher, M. M. Cro, S. Van Vogt, E. Cornelius, V. Lodrup Carlsen, K. C. Skjerven, H. O. Rehbinder, E. M. Lowe, A. Dissanayake, E. Shimojo, N. Yonezawa, K. Ohya, Y. Yamamoto-Hanada, K. Morita, K. Cork, M. Cooke, A. Simpson, E. L. McClanahan, D. Weidinger, S. Schmitt, J. Axon, E. Tran, L. Surber, C. Askie, L. M. Duley, L. Chalmers, J. R. Williams, H. C. Boyle, R. J.
CLINICAL AND EXPERIMENTAL ALLERGY, 2021     DOI:10.1111/cea.13847

Skin care interventions in infants for preventing eczema and food allergy

Kelleher, M. M. Cro, S. Cornelius, V. Lodrup Carlsen, K. C. Skjerven, H. O. Rehbinder, E. M. Lowe, A. J. Dissanayake, E. Shimojo, N. Yonezawa, K. Ohya, Y. Yamamoto-Hanada, K. Morita, K. Axon, E. Surber, C. Cork, M. Cooke, A. Tran, L. Van Vogt, E. Schmitt, J. Weidinger, S. McClanahan, D. Simpson, E. Duley, L. Askie, L. M. Chalmers, J. R. Williams, H. C. Boyle, R. J.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021     DOI:10.1002/14651858.CD013534.pub2

Personal innovative approach in radiation therapy of lung cancer- functional lung avoidance SPECT-guided (ASPECT) radiation therapy: a study protocol for phase II randomised double-blind clinical trial

Khalil, A. A. Hau, E. Gebski, V. Grau, C. Gee, H. Nyeng, T. B. West, K. Kramer, S. Farlow, D. Knap, M. Moller, D. S. Hoffmann, L. Farr, K. P.
BMC CANCER, 2021     DOI:10.1186/s12885-021-08663-1

Is it time to abandon clinical breast examination?

Kiely, B. E. Goodwin, A.
MEDICAL JOURNAL OF AUSTRALIA, 2021     DOI:10.5694/mja2.51285

The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a multi-attribute utility instrument derived from the cancer-specific FACT-General (FACT-G) quality of life questionnaire: development and Australian value set

King, M. T. Norman, R. Mercieca-Bebber, R. Costa, D. S. J. McTaggart-Cowan, H. Peacock, S. Janda, M. Muller, F. Viney, R. Pickard, A. S. Cella, D. Multi-Attribute Utility in Cancer, Consortium
VALUE IN HEALTH, 2021     DOI:10.1016/j.jval.2021.01.007

Clinical utility of plasma EGFR mutation detection with quantitative PCR in advanced lung cancer: A meta-analysis

Kok, P. S. Lee, K. Lord, S. Yang, J. C. Rosell, R. Goto, K. John, T. Wu, Y. L. Mok, T. S. K. Lee, C. K.
LUNG CANCER, 2021     DOI:10.1016/j.lungcan.2021.02.027

Tumor response end points as surrogates for overall survival in immune checkpoint inhibitor trials: A systematic review and meta-analysis

Kok, P. S. Yoon, W. H. Lord, S. Marschner, I. Friedlander, M. Lee, C. K.
JCO PRECIS ONCOL, 2021     DOI:10.1200/PO.21.00108

Barriers and potential solutions to international collaboration in neuro-oncology clinical trials: Challenges from the Australian perspective

Kong, B. Y. Carter, C. Nowak, A. K. Hovey, E. Lwin, Z. Haghighi, N. Gan, H. K. Sim, H. W. Ziegler, D. S. Barton, K. Parkinson, J. Leonard, R. Khasraw, M. Foote, M.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021     DOI:10.1111/ajco.13606

Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee

Kurtz, J. E. Gebski, V. Sukhin, V. Carey, M. Kong, I. Glasspool, R. M. Berek, J. S. de Paiva Batista, M. Hall, M. Kim, J. W. Yeoshoua, E. Fujiwara, N. Nam, B. H. Polleis, S. Lee, J. Y. Strojna, A. Farrelly, L. Schwameis, R. Fossati, R. Darlington, A. S. Lai, C. H. Wright, A. A. Rosenblat, O. Harter, P. Roxburgh, P. Chowdhury, R. R. Chang, T. C. Paoletti, X. Friedlander, M. Gynecologic Cancer InterGroup symptom benefit, committee
GYNECOLOGIC ONCOLOGY, 2021     DOI:10.1016/j.ygyno.2021.02.018

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group

Lacas, B. Carmel, A. Landais, C. Wong, S. J. Licitra, L. Tobias, J. S. Burtness, B. Ghi, M. G. Cohen, E. E. W. Grau, C. Wolf, G. Hitt, R. Corvo, R. Budach, V. Kumar, S. Laskar, S. G. Mazeron, J. J. Zhong, L. P. Dobrowsky, W. Ghadjar, P. Fallai, C. Zakotnik, B. Sharma, A. Bensadoun, R. J. Ruo Redda, M. G. Racadot, S. Fountzilas, G. Brizel, D. Rovea, P. Argiris, A. Nagy, Z. T. Lee, J. W. Fortpied, C. Harris, J. Bourhis, J. Auperin, A. Blanchard, P. Pignon, J. P. Mach-Nc Collaborative Group
RADIOTHERAPY AND ONCOLOGY, 2021     DOI:10.1016/j.radonc.2021.01.013

Rapid resistance of FGFR-driven gastric cancers to regorafenib and targeted FGFR inhibitors can be overcome by parallel inhibition of MEK

Lau, D. K. Luk, I. Y. Jenkins, L. J. Martin, A. Williams, D. S. Schoffer, K. L. Chionh, F. Buchert, M. Sjoquist, K. Boussioutas, A. Hayes, S. A. Ernst, M. Weickhardt, A. J. Pavlakis, N. Tebbutt, N. C. Mariadason, J. M.
MOLECULAR CANCER THERAPEUTICS, 2021     DOI:10.1158/1535-7163.MCT-20-0836

Return to work following laparoscopic-assisted resection or open resection for rectal cancer: Findings from AlaCaRT-Australasian Laparoscopic Cancer of the Rectum Trial

Law, C. K. Brewer, K. Brown, C. Wilson, K. Bailey, L. Hague, W. Simes, J. R. Stevenson, A. Solomon, M. Morton, R. L. Australasian Gastro-Intestinal Trials Group, ALaCaRT investigators
CANCER MED, 2021     DOI:10.1002/cam4.3623